Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi Sells 1,827 Shares

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 1,827 shares of the stock in a transaction that occurred on Wednesday, March 26th. The stock was sold at an average price of $27.46, for a total value of $50,169.42. Following the transaction, the chief financial officer now owns 103,591 shares in the company, valued at $2,844,608.86. The trade was a 1.73 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, February 18th, Balaji Gandhi sold 5,771 shares of Phreesia stock. The shares were sold at an average price of $30.04, for a total transaction of $173,360.84.
• On Thursday, February 13th, Balaji Gandhi sold 28,759 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total transaction of $862,770.00.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total transaction of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Stock Performance

Shares of PHR traded down $1.17 on Friday, reaching $26.00. 694,034 shares of the company’s stock traded hands, compared to its average volume of 428,890. The stock’s 50 day simple moving average is $27.40 and its two-hundred day simple moving average is $24.16. The stock has a market cap of $1.53 billion, a PE ratio of -17.69 and a beta of 1.03. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Institutional Investors Weigh In On Phreesia

Several large investors have recently made changes to their positions in PHR. Johnson Financial Group Inc. boosted its holdings in shares of Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock worth $28,000 after buying an additional 896 shares during the last quarter. R Squared Ltd purchased a new stake in Phreesia during the fourth quarter worth about $30,000. BankPlus Trust Department bought a new stake in Phreesia in the fourth quarter worth about $34,000. Quarry LP boosted its stake in Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after acquiring an additional 1,923 shares during the last quarter. Finally, Venturi Wealth Management LLC bought a new position in shares of Phreesia during the 4th quarter valued at approximately $76,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

PHR has been the subject of several research reports. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. Piper Sandler reissued an “overweight” rating and set a $33.00 target price (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Canaccord Genuity Group lifted their price target on Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, March 13th. Finally, Truist Financial increased their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Twelve investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has a consensus rating of “Buy” and an average price target of $31.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.